Indian student battles for life after car crash in US
Darpan News Desk IANS, 29 Nov, 2022 01:37 PM
New York, Nov 29 (IANS) An Indian student has been battling for life in a hospital after a car accident in New Jersey, the US, earlier this month that left him with a traumatic brain injury and several fractured ribs.
Vinamra Sharma, a student of New Jersey Institute of Technology, was "knocked unconscious" as he made his way home from the university campus on November 12.
He was rushed to Rutgers University Hospital, where he was diagnosed with a traumatic brain injury, a GoFundMe page, set up in Sharma's support, said Abhishek Sharma, who organised the GoFundMe initiative.
"He has been taken off a ventilator but still suffers from brain swelling due to multiple surgeries he has undergone in the last week," Abhishek added.
The page informed that within 10 days of the accident, Sharma has undergone four brain surgeries and is in the intensive care unit, hooked up to IVs and life support systems.
Back home in India, Sharma's parents are anxiously waiting for their US visa to be approved.
"We hope and pray that Vinamra will be out of the woods soon and begin his long road to recovery. At the moment, his treatment is focused on getting him to live. If he makes it, the focus of his treatment can shift to addressing the cognitive and physical mobility challenges," the page said.
Sharma's health insurance does not cover accident expenses, and he does not have auto insurance (he does not drive).
His current in-hospital expenses include doctor, surgeon and specialist consultations, ICU services, medical exams and miscellaneous hospital fees.
As of now, nearly $72,199 have been raised from the crowdfunding initiative, which will be transferred directly to the student's family.
Police found the victim off the side of a road with apparent gunshot wounds. The man died from his injuries at the scene and his identity is being withheld until his next of kin is notified, the police said.
WHO Director-General Tedros Adhanom Ghebreyesus said during a news briefing that Pfizer's treatment was still too expensive. He noted that most countries in Latin America had no access to Pfizer’s drug, Paxlovid , which has been shown to cut the risk of COVID-19 hospitalization or death by up to 90%.
Paxlovid has become the go-to option against COVID-19 because of its at-home convenience and impressive results in heading off severe disease. The U.S. government has spent more than $10 billion to purchase enough pills to treat 20 million people.
About two dozen states reported suspected cases after the Centers for Disease Control and Prevention put out a call for doctors to be on the lookout for surprising cases of hepatitis. The cases date back to late October in children under 10. So far, only nine cases in Alabama have been confirmed.
FDA officials said in a statement that they decided to restrict J&J's vaccine after taking another look at data on the risk of life-threatening blood clots within two week of vaccination.
Preliminary research suggests it is about 25 per cent more transmissible than the BA.2 subvariant that is currently dominant nationally, according to the Centers for Disease Control and Prevention.
